Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Opioid Use Disorder market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Opioid Use Disorder market. Detailed analysis of key players, along with key growth strategies adopted by Opioid Use Disorder industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
MediciNova
Indivior
Hikma Pharmaceuticals
Teva Pharmaceuticals
Omeros
Camurus
BioDelivery Sciences International Inc
Mallinckrodt Pharmaceuticals
Titan Pharmaceuticals
Alkermes
Orexo
Pfizer, Inc
By Type:
Buprenorphine
Methadone
Naltrexone
By End-User:
Severe Pain Treatment
Moderate Pain Treatment
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid Use Disorder Market
-
1.3 Market Segment by Type
-
1.3.1 China Opioid Use Disorder Market Size and Growth Rate of Buprenorphine from 2016 to 2027
-
1.3.2 China Opioid Use Disorder Market Size and Growth Rate of Methadone from 2016 to 2027
-
1.3.3 China Opioid Use Disorder Market Size and Growth Rate of Naltrexone from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Opioid Use Disorder Market Size and Growth Rate of Severe Pain Treatment from 2016 to 2027
-
1.4.2 China Opioid Use Disorder Market Size and Growth Rate of Moderate Pain Treatment from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Opioid Use Disorder Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Opioid Use Disorder by Major Types
-
3.4.1 Market Size and Growth Rate of Buprenorphine
-
3.4.2 Market Size and Growth Rate of Methadone
-
3.4.3 Market Size and Growth Rate of Naltrexone
4 Segmentation of Opioid Use Disorder Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Opioid Use Disorder by Major End-Users
-
4.4.1 Market Size and Growth Rate of Opioid Use Disorder in Severe Pain Treatment
-
4.4.2 Market Size and Growth Rate of Opioid Use Disorder in Moderate Pain Treatment
5 Market Analysis by Regions
-
5.1 China Opioid Use Disorder Production Analysis by Regions
-
5.2 China Opioid Use Disorder Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Opioid Use Disorder Landscape Analysis
-
6.1 North China Opioid Use Disorder Landscape Analysis by Major Types
-
6.2 North China Opioid Use Disorder Landscape Analysis by Major End-Users
7 Central China Opioid Use Disorder Landscape Analysis
-
7.1 Central China Opioid Use Disorder Landscape Analysis by Major Types
-
7.2 Central China Opioid Use Disorder Landscape Analysis by Major End-Users
8 South China Opioid Use Disorder Landscape Analysis
-
8.1 South China Opioid Use Disorder Landscape Analysis by Major Types
-
8.2 South China Opioid Use Disorder Landscape Analysis by Major End-Users
9 East China Opioid Use Disorder Landscape Analysis
-
9.1 East China Opioid Use Disorder Landscape Analysis by Major Types
-
9.2 East China Opioid Use Disorder Landscape Analysis by Major End-Users
10 Northeast China Opioid Use Disorder Landscape Analysis
-
10.1 Northeast China Opioid Use Disorder Landscape Analysis by Major Types
-
10.2 Northeast China Opioid Use Disorder Landscape Analysis by Major End-Users
11 Southwest China Opioid Use Disorder Landscape Analysis
-
11.1 Southwest China Opioid Use Disorder Landscape Analysis by Major Types
-
11.2 Southwest China Opioid Use Disorder Landscape Analysis by Major End-Users
12 Northwest China Opioid Use Disorder Landscape Analysis
-
12.1 Northwest China Opioid Use Disorder Landscape Analysis by Major Types
-
12.2 Northwest China Opioid Use Disorder Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 MediciNova
-
13.1.1 MediciNova Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Indivior
-
13.2.1 Indivior Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Hikma Pharmaceuticals
-
13.3.1 Hikma Pharmaceuticals Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Teva Pharmaceuticals
-
13.4.1 Teva Pharmaceuticals Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Omeros
-
13.5.1 Omeros Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Camurus
-
13.6.1 Camurus Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 BioDelivery Sciences International Inc
-
13.7.1 BioDelivery Sciences International Inc Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Mallinckrodt Pharmaceuticals
-
13.8.1 Mallinckrodt Pharmaceuticals Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Titan Pharmaceuticals
-
13.9.1 Titan Pharmaceuticals Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Alkermes
-
13.10.1 Alkermes Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Orexo
-
13.11.1 Orexo Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Pfizer, Inc
-
13.12.1 Pfizer, Inc Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Opioid Use Disorder Market Size and Growth Rate of Buprenorphine from 2016 to 2027
-
Figure China Opioid Use Disorder Market Size and Growth Rate of Methadone from 2016 to 2027
-
Figure China Opioid Use Disorder Market Size and Growth Rate of Naltrexone from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Opioid Use Disorder Market Size and Growth Rate of Severe Pain Treatment from 2016 to 2027
-
Figure China Opioid Use Disorder Market Size and Growth Rate of Moderate Pain Treatment from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Opioid Use Disorder Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Opioid Use Disorder
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Opioid Use Disorder by Different Types from 2016 to 2027
-
Table Consumption Share of Opioid Use Disorder by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Buprenorphine
-
Figure Market Size and Growth Rate of Methadone
-
Figure Market Size and Growth Rate of Naltrexone
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Opioid Use Disorder by Different End-Users from 2016 to 2027
-
Table Consumption Share of Opioid Use Disorder by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Severe Pain Treatment
-
Figure Market Size and Growth Rate of Moderate Pain Treatment
-
Table China Opioid Use Disorder Production by Regions
-
Table China Opioid Use Disorder Production Share by Regions
-
Figure China Opioid Use Disorder Production Share by Regions in 2016
-
Figure China Opioid Use Disorder Production Share by Regions in 2021
-
Figure China Opioid Use Disorder Production Share by Regions in 2027
-
Table China Opioid Use Disorder Consumption by Regions
-
Table China Opioid Use Disorder Consumption Share by Regions
-
Figure China Opioid Use Disorder Consumption Share by Regions in 2016
-
Figure China Opioid Use Disorder Consumption Share by Regions in 2021
-
Figure China Opioid Use Disorder Consumption Share by Regions in 2027
-
Table North China Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table North China Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure North China Opioid Use Disorder Consumption Share by Types in 2016
-
Figure North China Opioid Use Disorder Consumption Share by Types in 2021
-
Figure North China Opioid Use Disorder Consumption Share by Types in 2027
-
Table North China Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table North China Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure North China Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure North China Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure North China Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table Central China Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table Central China Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure Central China Opioid Use Disorder Consumption Share by Types in 2016
-
Figure Central China Opioid Use Disorder Consumption Share by Types in 2021
-
Figure Central China Opioid Use Disorder Consumption Share by Types in 2027
-
Table Central China Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table Central China Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure Central China Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure Central China Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table South China Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table South China Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure South China Opioid Use Disorder Consumption Share by Types in 2016
-
Figure South China Opioid Use Disorder Consumption Share by Types in 2021
-
Figure South China Opioid Use Disorder Consumption Share by Types in 2027
-
Table South China Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table South China Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure South China Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure South China Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure South China Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table East China Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table East China Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure East China Opioid Use Disorder Consumption Share by Types in 2016
-
Figure East China Opioid Use Disorder Consumption Share by Types in 2021
-
Figure East China Opioid Use Disorder Consumption Share by Types in 2027
-
Table East China Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table East China Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure East China Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure East China Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure East China Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table Northeast China Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table Northeast China Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Opioid Use Disorder Consumption Share by Types in 2016
-
Figure Northeast China Opioid Use Disorder Consumption Share by Types in 2021
-
Figure Northeast China Opioid Use Disorder Consumption Share by Types in 2027
-
Table Northeast China Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table Northeast China Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure Northeast China Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure Northeast China Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table Southwest China Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table Southwest China Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Opioid Use Disorder Consumption Share by Types in 2016
-
Figure Southwest China Opioid Use Disorder Consumption Share by Types in 2021
-
Figure Southwest China Opioid Use Disorder Consumption Share by Types in 2027
-
Table Southwest China Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table Southwest China Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure Southwest China Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure Southwest China Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table Northwest China Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table Northwest China Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Opioid Use Disorder Consumption Share by Types in 2016
-
Figure Northwest China Opioid Use Disorder Consumption Share by Types in 2021
-
Figure Northwest China Opioid Use Disorder Consumption Share by Types in 2027
-
Table Northwest China Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table Northwest China Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure Northwest China Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure Northwest China Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of MediciNova
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MediciNova
-
Figure Sales and Growth Rate Analysis of MediciNova
-
Figure Revenue and Market Share Analysis of MediciNova
-
Table Product and Service Introduction of MediciNova
-
Table Company Profile and Development Status of Indivior
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indivior
-
Figure Sales and Growth Rate Analysis of Indivior
-
Figure Revenue and Market Share Analysis of Indivior
-
Table Product and Service Introduction of Indivior
-
Table Company Profile and Development Status of Hikma Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hikma Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Hikma Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Hikma Pharmaceuticals
-
Table Product and Service Introduction of Hikma Pharmaceuticals
-
Table Company Profile and Development Status of Teva Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Teva Pharmaceuticals
-
Table Product and Service Introduction of Teva Pharmaceuticals
-
Table Company Profile and Development Status of Omeros
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Omeros
-
Figure Sales and Growth Rate Analysis of Omeros
-
Figure Revenue and Market Share Analysis of Omeros
-
Table Product and Service Introduction of Omeros
-
Table Company Profile and Development Status of Camurus
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Camurus
-
Figure Sales and Growth Rate Analysis of Camurus
-
Figure Revenue and Market Share Analysis of Camurus
-
Table Product and Service Introduction of Camurus
-
Table Company Profile and Development Status of BioDelivery Sciences International Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioDelivery Sciences International Inc
-
Figure Sales and Growth Rate Analysis of BioDelivery Sciences International Inc
-
Figure Revenue and Market Share Analysis of BioDelivery Sciences International Inc
-
Table Product and Service Introduction of BioDelivery Sciences International Inc
-
Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals
-
Table Product and Service Introduction of Mallinckrodt Pharmaceuticals
-
Table Company Profile and Development Status of Titan Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Titan Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Titan Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Titan Pharmaceuticals
-
Table Product and Service Introduction of Titan Pharmaceuticals
-
Table Company Profile and Development Status of Alkermes
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alkermes
-
Figure Sales and Growth Rate Analysis of Alkermes
-
Figure Revenue and Market Share Analysis of Alkermes
-
Table Product and Service Introduction of Alkermes
-
Table Company Profile and Development Status of Orexo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orexo
-
Figure Sales and Growth Rate Analysis of Orexo
-
Figure Revenue and Market Share Analysis of Orexo
-
Table Product and Service Introduction of Orexo
-
Table Company Profile and Development Status of Pfizer, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc
-
Figure Sales and Growth Rate Analysis of Pfizer, Inc
-
Figure Revenue and Market Share Analysis of Pfizer, Inc
-
Table Product and Service Introduction of Pfizer, Inc
-
